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ARTICLE OPEN
Caffeic acid phenethyl ester protects against oxidative stress
and dampens inﬂammation via heme oxygenase 1
Alexandra Stähli 1,2, Ceeneena Ubaidha Maheen1, Franz Josef Strauss 1,3, Sigrun Eick 2, Anton Sculean2 and Reinhard Gruber 1,2,4
Periodontal disease is associated with chronic oxidative stress and inﬂammation. Caffeic acid phenethyl ester (CAPE), which is a
potent inducer of heme oxygenase 1 (HO1), is a central active component of propolis, and the application of propolis improves
periodontal status in diabetic patients. Here, primary murine macrophages were exposed to CAPE. Target gene expression was
assessed by whole-genome microarray, RT-PCR and Western blotting. The antioxidative and anti-inﬂammatory activities of CAPE
were examined by exposure of the cells to hydrogen peroxide, saliva and periodontal pathogens. The involvement of HO1 was
investigated with the HO1 inhibitor tin protoporphyrin (SnPP) and knockout mice for Nrf2, which is a transcription factor for
detoxifying enzymes. CAPE increased HO1 and other heat shock proteins in murine macrophages. A p38 MAPK inhibitor and Nrf2
knockout attenuated CAPE-induced HO1 expression in macrophages. CAPE exerted strong antioxidative activity. Additionally, CAPE
reduced the inﬂammatory response to saliva and periodontal pathogens. Blocking HO1 decreased the antioxidative activity and
attenuated the anti-inﬂammatory activity of CAPE. In conclusion, CAPE exerted its antioxidative effects through the Nrf2-mediated
HO1 pathway and its anti-inﬂammatory effects through NF-κB inhibition. However, preclinical models evaluating the use of CAPE in
periodontal inﬂammation are necessary in future studies.
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INTRODUCTION
Caffeic acid phenethyl ester (CAPE) is a central active component
of propolis from honeybee hives. Propolis has multiple applica-
tions in dentistry. Systemic propolis improved the periodontal
status in patients with type 2 diabetes,1 and local propolis
application reduced plaque accumulation, gingival inﬂammation2
and oral mucositis during chemotherapy.3 In preclinical models,
CAPE protected against ligature-induced periodontitis4 and
systemic bone loss by cortisone,5 and supported bone defect
healing.6 Therefore, CAPE is attracting attention in periodontol-
ogy,7,8 and interest is growing in uncovering the beneﬁcial effects
of CAPE in periodontal therapy.
Periodontal disease is characterised by chronic inﬂammation9
and the concurrent challenge of oxidative stress,10,11 which
together culminate in oral tissue destruction and ultimately tooth
loss. Therefore, CAPE is of potential clinical interest. For example,
CAPE prevents damage of cells exposed to hydrogen peroxide,
including neurite PC12 cells,12 retinal 661W cells13 and umbilical
vein endothelial cells.14 CAPE also exerts anti-inﬂammatory activity
in gingival ﬁbroblasts7 and macrophages8 exposed to endotoxins.
Thus, CAPE supports the major defence mechanisms of cells
challenged by oxidative stress and inﬂammation.
Nuclear factor erythroid 2-related factor 2 (Nrf2) is released from
its suppressor Kelch-like ECH-associated protein 1 (Keap1) upon
stimulation with CAPE.15,16 Nrf2 translocates into the nucleus and
initiates the transcription of heme oxygenase 1 (HO1). HO1, which
is linked to orthodontic tooth movement17,18 and inﬂammation in
a periodontitis model,10 is a major target of CAPE. For instance,
CAPE increases HO1 expression in gingival ﬁbroblasts7 and
macrophages.8 In turn, HO1 activates the cellular defence
mechanisms against oxidative stress,19 including superoxide
dismutase (SOD), catalase (CAT) and glutathione S-transferase
(GST) expression.20 In support of this mechanism, Nrf221 and
HO122,23 regulate SOD expression.
Tin protoporphyrin IX dichloride (SnPP) blocks HO1 activity,
which allows insights into the role of HO1 in anti-inﬂammatory
activity in macrophages24 and periodontal cells.25 Moreover, Nrf2
activation participates in the inhibitory effect of CAPE on nuclear
factor-κappa-B (NF-κB) signalling.26 Independent of HO1, CAPE
inhibits lipopolysaccharide (LPS)-induced interleukin (IL)-1β
expression in RAW264.7 cells8 and inﬂammation in epithelial
cells.27 However, CAPE requires HO1 to exert its anti-inﬂammatory
activity, such as LPS-induced nitric oxide production, in RAW264.7
cells.8 Thus, the data are heterogeneous with respect to the ability
of HO1 to mediate the anti-inﬂammatory activity of CAPE.
Mitogen-activated protein kinase (MAPK) may contribute to the
CAPE-induced increase in HO1 expression. For example, the p38
MAPK inhibitor SB203580 attenuates the HO1 expression induced
by CAPE.28 SB203580 also decreases HO1 expression in other
in vitro models, including neuronal cells29 and RAW264.7
macrophages.30–32 Thus, the ability of CAPE to regulate HO1 and
consequently to counteract oxidative stress and inﬂammation
may involve p38 MAPK signalling.
The aim of the present study was to perform a genome-wide
screening approach to evaluate CAPE-regulated genes and to use
functional assays to better understand the role of HO1 in
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coordinating the cellular defence against oxidative stress and
inﬂammation.
RESULTS
CAPE increases heat shock proteins
Based on a whole-genome microarray, treatment of three
independent preparations of primary murine macrophages with
CAPE caused expression changes of ﬁve characteristic stress-
response genes more than 10-fold: Hspa1a (HSP70), Hspa1b, Hsph1
(HSP105, member of the HSP70 family), growth arrest and DNA-
damage-inducible protein GADD45 gamma (Gadd45g)33 and
adrenomedullin (ADM)34 (Fig. 1a). Increased Hspa1a, Hspa1b, Hsph1,
Gadd45g and ADM expression was conﬁrmed by reverse
transcription-PCR (RT-PCR) analysis (Fig. 1b). Considering that heat
shock proteins include HO1 (Hsp32), which is frequently co-
expressed,35 and that CAPE is a known activator of HO1 expression
in gingival ﬁbroblasts7 and macrophages,8 we introduced SnPP,
which is an inhibitor raised against HO1.36 SnPP almost abolished
the CAPE-induced increase in Hsp and Gadd45g expression (Fig. 1c).
CAPE increases HO1 expression
Next, we conﬁrmed that CAPE was capable of increasing HO1
expression in murine macrophages and gingival ﬁbroblasts. HO1
expression was considerably increased by CAPE in primary
macrophages, RAW264.7 cells and gingival ﬁbroblasts (Fig. 2a).
HO1 was also increased at the protein level in macrophages as
determined by Western blotting analysis (Fig. 2b). In macro-
phages, blocking p38 MAPK with SB203580 but not JNK and ERK
attenuated the increase in HO1 expression (Fig. 2c). Moreover,
cells from Nrf2-knockout mice displayed reduced HO1 expression
in response to CAPE (Fig. 2d). Time-response experiments showed
a peak in HO1 gene expression changes after 3–12 hours (Fig. S1).
HO1 mediates the antioxidative activity of CAPE
To determine whether CAPE could support the ability of cells to
cope with oxidative stress, various periodontal cell types were
exposed to hydrogen peroxide. As predicted,12–14 hydrogen
peroxide decreased the viability of HSC-2, MC3T3-E1 and gingival
ﬁbroblasts, as indicated by the reduced capacity to form formazan
crystals (Fig. 3a) and reduced trypan blue staining of the HSC-2
cells (Fig. 3b). Blocking HO1 activity with SnPP reversed the
positive effects of CAPE in the various cell types (Fig. 3a, b).
Moreover, SnPP counteracted the increased SOD expression
induced by CAPE (Fig. 3c). A trend towards lower CAT and GST
expression by SnPP was also observed but failed to reach the level
of signiﬁcance (Fig. 3c).
HO1 and inhibition of NF-κB subunit p65 control the anti-
inﬂammatory activity of CAPE
In support of previous data,37 primary macrophages showed a
massive inﬂammatory response when exposed to human
saliva (Fig. 4a). In the presence of CAPE, the strong proin-
ﬂammatory response was almost abolished (Fig. 4a). Moreo-
ver, CAPE greatly suppressed the inﬂammatory response of
macrophages exposed to supernatants of periodontal patho-
gens (e.g. Porphyromonas gingivalis, Treponema denticola and
Tannerella forsythia) (Fig. S2). Next, we sought to investigate
whether HO1 mediated the anti-inﬂammatory response of CAPE.
SnPP reversed the anti-inﬂammatory effect of CAPE on saliva-
induced IL-1α and IL-1β expression in primary macrophages
but not in RAW264.7 cells (Fig. 4b, c). In support of previous
ﬁndings,8,38 CAPE inhibited the translocation of p65 into the
nucleus in RAW264.7 cells exposed to inﬂammatory clues.
As expected, inhibition of p65 translocation by CAPE in
RAW264.7 cells occurred independent of SnPP (Fig. 4d and
Fig. 5).
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Fig. 1 CAPE target genes assessed by microarray analysis and RT-PCR. Primary murine macrophages were incubated overnight with
10 µmol·L−1 CAPE. Microarrays of three independent experiments were analysed. Genes showing a more than 10-fold change were further
analysed and compared among the three experiments. (a) The intersection of CAPE-induced genes between the experiments. RT-PCR was
performed for Hspa1a, Hspa1b, Hsph1, Gadd45g and ADM (b), n= 3–5. The data represent the mean ± SD. *P < 0.05, **P < 0.01 and ***P <
0.001 in the two-tailed Mann-Whitney test
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DISCUSSION
Chronic inﬂammation in periodontitis is accompanied by oxidative
stress, which together culminate in the catabolic events that
ultimately lead to tissue destruction and tooth loss.39,40 One
potential therapeutic strategy to regain periodontal health apart
from scaling and root planing is to curtail inﬂammation and
oxidative stress by local application of CAPE. Initial support for this
hypothesis came from observations that propolis improved the
periodontal status in type 2 diabetes patients1 and that CAPE
protected against ligature-induced periodontitis in rats.4 CAPE also
protects against other detrimental conditions, including peptido-
glycan polysaccharide-induced colitis,41 Cr(VI)-induced brain
toxicity,42 acetylsalicylic acid-induced lung damage,43 cyclosporine
A-induced nephrotoxicity,44 cerulean-induced acute pancreatitis,45
cholestatic liver injury induced by bile duct ligation46 and acute
myocardial ischaemia/reperfusion injury.47 Therefore, CAPE
reduces detrimental effects related to inﬂammation and also
exerts cytotoxic activity. Our intention was to extend the existing
knowledge of how CAPE helps cells in the periodontium cope with
inﬂammatory cues and hydrogen peroxide.
To screen for CAPE target genes, a microarray analysis was
performed, which revealed a more than 10-fold increase in
Hspa1a, Hspa1b, Hsph1, Gadd45g and ADM expression in murine
macrophages. CAPE was reported to increase HspA5 expression in
neuroblastoma cells48 and Hspa1a/Hspa1b expression in endothe-
lial cells.49 With respect to possible relevance to periodontology,
Hspa1a is upregulated in the periodontal ligament at the early
stage of tooth movement in rats.50 Hydrogen sulphide-exposed
oral keratinocyte stem cells express Gadd45g51 and ADM was
detected in human gingival crevicular ﬂuid.52 Moreover, we can
reasonably suggest that Hsps, Gadd45g and ADM play a role in
defence of the periodontium against oral pathogens, because
recombinant Hsp70 protects cells from oxidative stress53 and
reduces inﬂammation in sepsis models.54 Gadd45 proteins are
implicated in cell cycle checkpoints, apoptosis and DNA repair.55
ADM not only regulates the vascular tonus but also has
antioxidant and anti-inﬂammatory properties with therapeutic
potential for myocardial infarction and inﬂammatory bowel
diseases.56
Hspa1a, Hspa1b, Hsph1 and Gadd45g expression was reduced
by blocking HO1 activity with SnPP. Surprisingly, HO1 did not
reach the 10-fold expression level in the gene array that it
achieved in the RT-PCR. As expected, HO1 expression was
increased by CAPE in all cell types investigated, including primary
macrophages, RAW264.7 macrophages and gingival ﬁbroblasts.
These ﬁndings support a role for CAPE as a potent agonist of HO1
expression in gingival ﬁbroblasts7 and macrophages.8 However,
we cannot state the percentage of HO1-positive cells, because no
ﬂow cytometry analysis was performed. To further explore the
underlying signalling mechanism, the MAPKs were blocked.
SB203580 attenuated the increased HO1 expression induced by
CAPE. These ﬁndings are in support of the ability of p38 to
regulate CAPE-induced HO1 expression in rat organotypic
midbrain slice cultures.28 MAPK signalling has been implicated
in Nrf2 induction. However, whether this effect occurs directly
through phosphorylation of Nrf2 or through indirect and less
speciﬁc mechanisms is unclear. Although inhibition of p38
abolished Nrf2 activation in glial cells,57 genetic deﬁciency or
pharmacological inhibition of p38 increased HO1 expression
through a Nrf2-dependent pathway.58 Considering the role of
Nrf2 as an upstream regulator of HO1, cells from Nrf2-knockout
mice displayed reduced HO1 expression in response to CAPE.
These ﬁndings are in agreement with the release of Keap1 upon
stimulation with CAPE,15,16 which allowed Nrf2 to initiate HO1
transcription.
In the present study, blocking HO1 with SnPP partially reversed
the protective effects of CAPE on hydrogen peroxide damage
similar to the other HO1 inducers quercetin59 and baicalein.60 In
support of this functional assay, SnPP reduced CAPE-induced SOD
expression. These ﬁndings were in line with reports showing that
SnPP decreased SOD in smoke-induced emphysema rats.61
Additionally, a moderate decrease was observed in CAT, which
is the enzyme that catalyses the decomposition of hydrogen
peroxide to water and oxygen, and GST in this setting. Together,
the data suggested that CAPE increased HO1 expression, which in
turn drove SOD expression and probably that of other detoxifying
enzymes to avoid hydrogen peroxide-induced cell death.
Here, SnPP increased the expression of inﬂammatory cytokines
in primary macrophages, suggesting that the anti-inﬂammatory
activity of CAPE required HO1 activity. However, SnPP did not
modulate the anti-inﬂammatory effects of CAPE in RAW264.7 cells.
In support of previous ﬁndings,8,38 CAPE inhibited translocation of
p65 into the nucleus, thereby reducing the transmission of
proinﬂammatory signals. Again, SnPP failed to reverse the effects
of CAPE by blocking the translocation of p65 into the nucleus in
RAW264.7 cells, suggesting that the anti-inﬂammatory activity of
CAPE was independent of HO1 activity. Similar to our observations
with primary macrophages, SnPP attenuated the inhibitory effects
of ﬂavonoids and hemin on LPS-induced inﬂammatory production
in macrophages24 and sappanchalcone in LPS-stimulated human
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Fig. 2 CAPE induces HO1 gene expression. Murine macrophages and RAW264.7 cells were stimulated overnight with 10 µmol·L−1 CAPE, and
gingival ﬁbroblasts were stimulated with 20 µmol·L−1 CAPE. HO1 gene expression was assessed (a), n= 3. HO1 protein expression was
assessed by Western blotting in murine macrophages (b). Only relevant signals are shown. The full-length blots are presented in
Supplementary Fig. 3. The impact of MAPK signalling was investigated using the respective inhibitors (SP600125 for JNK, SB203580 for p38
and U0126 for ERK) (c), n= 3. HO1 gene expression was further investigated in the Nrf2−/−mice (d), n= 3. Data represent the mean ± SD. *P <
0.05 and **P < 0.01 in the two-tailed Mann-Whitney test
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periodontal ligament cells.25 However, CAPE dampened inﬂam-
mation in epithelial cells27 and LPS-induced IL-1β production in
RAW264.7 cells8 independent of HO1 signalling. Therefore, HO1 is
not necessarily involved in mediating the anti-inﬂammatory
activity of CAPE in vitro. Nevertheless, our cumulative in vitro
data suggest that CAPE-induced HO1 may be a central regulator
that helps cells cope with oxidative stress and inﬂammation.
Support for this hypothesis came from studies in which SnPP
reversed the beneﬁcial effects of baicalein and other HO1
inducers. For example, SnPP abolished the baicalein-, tetramethyl-
pyrazine- and cepharanthine-mediated protection against ischae-
mia/reperfusion injury in various models.22,62,63 Future studies
with CAPE should involve SnPP to reveal the role of HO1 in vivo.
The clinical relevance of the data presented here is based on
revealing the molecular and cellular mechanisms of the beneﬁcial
effects of propolis on oral health.1–3 Its major bioactive
component (CAPE) protects against ligature-induced periodonti-
tis4 and systemic bone loss by cortisone5 and supports bone
defect healing.6 Considering that periodontal disease is caused by
chronic inﬂammation9 and oxidative stress10,11 and that CAPE
suppresses inﬂammation and oxidative damage, our in vitro
ﬁndings provide indirect support for HO1 as a target of period-
ontal therapy. Our data may also serve as a primer to extend this
research to other ﬁelds in dentistry, including mucositis, peri-
implantitis and pulpitis. However, care should be taken concern-
ing the possible side effects of CAPE. For example, CAPE can have
a strong antimitogenic activity in lung cancer, prostate cancer,
melanoma,64 breast cancer65 and oral cancer.66 CAPE exerted
cytotoxic effects on neck metastasis of gingiva carcinoma and
tongue squamous cell carcinoma cells.67 Hence, safety and
efﬁcacy studies are required prior to clinical topical application
of CAPE in the periodontium.
CONCLUSION
Here we show that CAPE exerts its antioxidative effects through
Nrf2-mediated HO1 expression and its anti-inﬂammatory activity
through NF-κB inhibition.
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Fig. 3 CAPE protects cells from oxidative stress. HSC-2, MC3T3-E1 cells and gingival ﬁbroblasts were incubated with 1% H2O2 for 3 h with and
without CAPE and the HO1 inhibitor SnPP. The MTT conversion assay showed that the presence of CAPE reduced the lethal effect of H2O2. Co-
stimulation with SnPP reversed the rescue effects of CAPE (a), n= 3. The results were conﬁrmed by phase contrast microscopy and trypan blue
staining. Blue-stained cells represent dead cells (b), n= 3. Induction of the antioxidant enzymes superoxide dismutase (SOD), catalase (CAT)
and glutathione S-transferase (GST) after CAPE stimulation was evaluated in murine macrophages (c), n= 3. The data represent the mean ± SD.
*P < 0.05, **P < 0.01 and ***P < 0.001 in the Kruskal-Wallis test with Dunn’s multiple comparisons correction and the two-tailed Mann-Whitney
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MATERIALS AND METHODS
Murine bone marrow macrophages, human gingival ﬁbroblasts
and cell lines
Bone marrow cells were isolated from the femora and tibiae of
BALB/c mice aged 6–8 weeks, seeded at a density of 1 × 106 cells
per cm2 into 12-well plates (CytoOne, Starlab GmbH, Hamburg,
Germany) and grown for 7 days in Dulbecco’s modiﬁed medium
(α-MEM) supplemented with 10% fetal bovine serum, 1% anti-
biotics (all from Invitrogen, Grand Island, NY, USA; growth
medium) and 15% supernatant from L-929 cells (CCL-1™, American
Type Culture Collection, Manassas, VA, USA).68 Osteoblastic
MC3T3-E1 cells were originally obtained from Dr. Kumegawa
(Josai Dental University, Sakado, Japan). RAW264.7 cells (ATCC®
TIB-71™) were obtained from the American Type Culture Collec-
tion. Human gingival ﬁbroblasts were harvested from wisdom
teeth extractions from patients who had given informed and
written consent. Approval was obtained from the Ethics Commit-
tee of the Medical University of Vienna (EK NR 631/2007). All
methods were performed in full accordance with the relevant
guidelines and regulations. Tissue specimens were washed in
phosphate-buffered saline (PBS) and culture medium for 2–3min,
cut into pieces 2 mm× 2mm in size and placed into culture ﬂasks.
After 2–3min, the ﬂasks were ﬂooded with culture medium
(DMEM, pH 7.2) supplemented with 10% fetal calf serum and
1% antibiotics. Gingival ﬁbroblasts that grew out from the
explants were used for the experiments. Two strains of ﬁbroblasts
were established and were used for the experiments before
passage 10. The oral squamous cell carcinoma cell line HSC-2 was
obtained from the Japan Health Sciences Foundation (Health
Science Research Resources Bank, JCRBD 6222). The cells were
seeded at a concentration of 3 × 104 cells per cm² into culture
dishes 1 day prior to stimulation. The CAPE concentration was
evaluated by 3-[4,5-dimethythiazol-2-yl]−2,5-diphenyltetrazolium
bromide (MTT) assay (data not shown) and was in line with the
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Fig. 5 Flowchart of experiments. After identiﬁcation of CAPE-
induced genes by microarray analysis, the results were conﬁrmed
by PCR and Western blot. Functional analysis was performed using
PCR, immunostaining or trypan blue staining
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concentrations reported in the literature. Cells were exposed to
CAPE (Sigma, St. Louis, MO, USA) at a 10-μmol·L−1 concentration in
serum-free medium either alone or in the presence of its inhibitor
tin protoporphyrin IX dichloride (SnPP; Sigma) at a concentration
of 10 μmol·L−1 for 12 hours. To block the main MAPK signalling
pathways, the pharmacologic inhibitors SP600125, SB203580 and
U0126 were used, all at 10-μmol·L−1 concentrations (Santa Cruz
Biotechnology, SCBT; Santa Cruz, CA, USA).
Cell viability
For the viability experiments, the cells were incubated with CAPE
with or without SnPP for 30 min prior to exposure to 1% H2O2.
After 3 h, the cell viability assay and trypan blue staining were
performed. For cell viability, MTT (Sigma) solution at a ﬁnal
concentration of 0.5 mg·mL−1 was added to each well of a
microtiter plate (CytoOne) and incubated for 2 h at 37 °C. Then,
the medium was removed, and the formazan crystals were
solubilized with dimethyl sulphoxide. The optical density was
measured at 570 nm. The data are expressed as percentages of
the optical density in the treatment groups normalised to the
unstimulated control values. Moreover, 50 μL of 0.4% trypan
blue (Sigma) was added to each well and incubated for 5 min at
room temperature. Then, the trypan blue solution was dis-
carded, and the cells were examined by microscopy and
photographed.
Cell inﬂammatory response
For the inﬂammation experiments, the cells were incubated with
CAPE with or without SnPP prior to exposure to 1% sterile saliva.
After 24 h, the supernatant was harvested, and RNA was
isolated. Whole human saliva was collected from two authors (R.
G. and A.S.), who were non-smokers and gave their informed
consent. Saliva ﬂow was stimulated by chewing parafﬁn wax
(Ivoclar Vivadent AG, Schaan, Liechtenstein) without eating and
drinking for 1 h prior to collection. Immediately after collection,
the saliva was centrifuged at 4 000 × g for 5 min. The saliva
supernatant was passed through a ﬁlter with a 0.2-μm pore
diameter (Diaﬁl PS, Graphic Controls/DIA-Nielsen GmbH & Co. KG,
Düren, Germany).
Whole-genome gene array
Total RNA was harvested from primary murine macrophages with
the RNA Isolation Kit (Extractme, BLIRT S.A., Gdańsk, Poland). The
RNA quality was determined using the Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA, USA). A total of 100 ng of
total RNA was ampliﬁed and labelled using the Genechip® WT
PLUS Reagent Kit (Catalogue Number 902281, Affymetrix, Santa
Clara, CA, USA). Labelled RNA samples were hybridised onto the
Affymetrix GeneChip® Mouse Gene 2.1 ST Array. The array plate
was washed, stained and scanned using the Affymetrix Gene Titan
according to the Gene Titan® Instrument User Guide for expression
array plates. Genes with at least 10-fold regulation in three
independent experiments were selected with Venny (http://
bioinfogp.cnb.csic.es/tools/venny/).
RT-PCR and immunoassay
RT was performed with the SensiFAST™ cDNA Synthesis Kit
(Bioline Reagents Ltd., London, UK). The RT-PCR was performed
with the SensiFAST™ SYBR® Kit following the manufacturer’s
instructions (Bioline). Ampliﬁcation was performed with the
StepOnePlus Real-Time PCR System (Applied Biosystems, Life
Technologies, Carlsbad, CA, USA). The primer sequences are given
in Table 1. Relative gene expression was calculated with the delta
delta CT method. The reactions were run in duplicate. The IL-1α in
the supernatant was analysed using an immunoassay kit
according to the manufacturer’s instructions (R&D Systems,
Minneapolis, MN, USA).
Western blotting
Macrophages were serum-starved overnight and then treated
overnight with CAPE as indicated. Cell extracts containing SDS
buffer and protease inhibitors (PhosSTOP with cOmplete; Sigma,
St. Louis, MO, USA) were separated by SDS-polyacrylamide gel
electrophoresis and transferred onto nitrocellulose membranes
(Whatman, GE Healthcare, General Electric Company, Fairﬁeld, CT,
USA). The membranes were blocked, and binding of the primary
antibody (HO1 polyclonal antibody, Enzo Life Sciences, Farming-
dale, NY, USA) was detected with an appropriate secondary
antibody directly labelled with near-infrared dyes (LI-COR
Biosciences, Lincoln, NE, USA) and visualised with an appropriate
imaging system (LI-COR). The acquired images were not
processed.
Bacterial cultures
Bacterial cultures of P. gingivalis, T. denticola and T. forsythia were
grown in Schaedler broth (Oxoid Basingstoke, GB) supplemented
with 0.25 mg·L−1 of vitamin K (and 10 mg of N-acetyl muramic
acid for T. forsythia) and modiﬁed mycoplasma broth (BD,
Franklin Lake, NJ, USA) supplemented with 1 mg·mL−1 of glucose,
400 mg· mL−1 of niacinamide, 150 mg·mL−1 of spermine tetra-
hydrochloride, 20 mg·mL−1 of Na isobutyrate enriched with
1 g·mL−1 of cysteine and 5mg·mL−1of cocarboxylase. Forty-
eight-hour broth cultures of the bacteria were centrifuged. The
resulting supernatants were ﬁltered through 400-μm membranes,
and the sediments were exposed to intensive ultrasonication for
10 min.
Immunostaining
Immunoﬂuorescent analysis of NF-κB p65 was performed in
RAW264.7 cells plated onto Millicell® EZ slides (Merck KGaA,
Darmstadt, Germany) and treated with 10 μmol·L−1 CAPE for 30
min prior to exposure to 1% saliva. The cells were ﬁxed in
paraformaldehyde and blocked with 1% bovine serum albumin
and 0.3% Triton in PBS at room temperature for 1 h. Then, the
cells were incubated with a NF-κB p65 primary antibody (1:100;
Cell Signaling Technology, USA). An Alexa 488 secondary
antibody (1:200, Santa Cruz Biotechnology, USA) was
applied for 1 h. The cells were washed, the nuclei were stained
with 4′,6-diamidino-2-phenylindole (100 ng·mL−1) and the cells
were mounted onto glass slides. Fluorescent images were
captured at ×100 in oil immersion using a Zeiss Axiovert 200M
ﬂuorescence microscope.
Table 1 Primer sequences
Primer Sequence_F Sequence_R
mHO1 CAATGTGGGCTTCTC TTTTGGTGAGGGAAC
mHspa1a GGCCAGGGCTGGATTACT GCAACCACCATGCAAGATTA
mHspa1b GAAGACATATAGTCTAGCTGCCCAGt CCAAGACGTTTGTTTAAGACACTTT
mHsph1 TGTTTTGCATTTTGCTCTCTTCA AAAGCCCTTATGCAAATCAGAC
mGadd45g GAATAACTTGCTGTTCGTGGA AAGTTCGTGCAGTGCTTTCC
mADM GGACACTGCAGGGCCAGAT GTAGTTCCCTCTTCCCACGACTTA
mIL1a TTGGTTAAATGACCTGCA GAGCGCTCACGAACAGT
mIL1b AAGGGCTGCTTCCAAACCTTTGAC ATACTGCCTGCCTGAAGCTCTTGT
mIL6 GCTACCAAACTGGATATAATCAGGA CCAGGTAGCTATGGTACTCCAGAA
mSOD CTCTTGGGAGAGCCTGACA GCCAGTAGCAAGCCGTAGAA
mCAT CCTTCAAGTTGGTTAATGCAGA CAAGTTTTTGATGCCCTGGT
mGST GGCAGAATGGAGTGCATCA TCCAAATCTTCCGGACTCTG
mGAPDH AACTTTGGCATTGTG GGATGCAGGGATGAT
mbactin CTAAGGCCAACCGTGAAAAG ACCAGAGGCATACAGGGACA
hHO1 ACATCTATGTGGCCCTGGAG GTTGAGCAGGAACGCAGTCT
hGAPDH AAGCCACATCGCTCAGACAC GCCCAATACGACCAAATCC
hactin CCAACCGCGAGAAGATGA CCAGAGGCGTACAGGGATAG
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Statistical analysis
The primary culture experiments were performed at least three
times. All experiments were repeated three to ﬁve times. The bars
show the means and standard deviations of cumulative data from all
experiments. The statistical analysis was based on the Mann-Whitney
U test and Kruskal-Wallis test with Dunn’s multiple comparisons
correction. The analyses were performed using Prism v7 (GraphPad
Software, La Jolia, CA, USA). Signiﬁcance was set at P< 0.05.
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